Results 91 to 100 of about 2,763 (183)

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study

Patient Preference and Adherence
Oralee J Varnado,1 Brenna L Brady,2 Anthony J Zagar,1 Yvonne P Robles,2 Margaret Hoyt1 1Eli Lilly and Company, Indianapolis, IN, USA; 2Merative, Ann Arbor, MI, USACorrespondence: Oralee J VarnadoValue, Evidence, and Outcomes, Eli Lilly and Company, Lilly
Varnado OJ, Brady BL, Zagar AJ, Robles YP, Hoyt M   +4 more
doaj  

Unveiling the efficacy and safety of Erenumab, a monoclonal antibody targeting calcitonin gene-related peptide (CGRP) receptor, in patients with chronic and episodic migraine: a GRADE-assessed systematic review and meta-analysis of randomized clinical trials with subgroup analysis

Head & Face Medicine
Background Migraine is a highly prevalent and disabling disease, affecting nearly 14% of the global population. Preventive medications involve drugs like beta-adrenergic blockers, antidepressants, and anticonvulsants.
Mohamed E. Haseeb, Hazem E. Mohammed, Hatem Yaser, George Hanen, Mohamed Nasser, Shehab Yaser, Zeyad Bady   +6 more
doaj   +1 more source

Real-world effectiveness of erenumab in Japanese patients with migraine

Background: Real-world evidence of erenumab effectiveness in migraine patients in Asia with various comorbidities and multiple previous medication failures is still limited.
Mukuto Shioda, Shiho Suzuki, Tomohiko Shiina, Koichi Hirata, Keisuke Suzuki, Saro Kobayashi, Yasuo Haruyama   +6 more
core   +1 more source

Erenumab u prevenciji migrenske glavobolje – pilot studija

This research aimed to assess the efficiency of erenumab (Aimovig) in the preventive treatment of patients with episodic and chronic migraines. In Croatia, migraine prevention is applied to patients with ≥ 4 days of migraine headaches per month ...
Titlić, Marina, Mihalj, Mario, Romac, Rinaldo, Ćurković Katić, Ana   +3 more
core   +1 more source

Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab

Journal of Pain Research, 2017
Maria Adele Giamberardino,1,* Giannapia Affaitati,1,* Raffaele Costantini,2 Francesco Cipollone,3,* Paolo Martelletti4,* 1Department of Medicine and Science of Aging, Headache Center, Geriatrics Clinic and Ce.S.I.-Met, “G.
Giamberardino MA, Affaitati G, Costantini R, Cipollone F, Martelletti P   +4 more
doaj  

Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab

BackgroundThe present study aimed to investigate the predictive value of calcitonin gene-related peptide (CGRP)-induced migraine attacks for effectiveness to erenumab treatment in people with migraine.MethodsIn total, 139 participants with migraine ...
Ashina, Håkan, Maio-Twofoot, Tina, Christensen, Rune Häckert, Wiggers, Astrid, Schytz, Henrik W., Snellman, Josefin, Ashina, Messoud, Iljazi, Afrim, Amin, Faisal Mohammad, Al-Khazali, Haidar M., Rose, Kathrine   +10 more
core   +1 more source

Real-world short-term effectiveness of erenumab after single versus multiple prior preventive treatment failures. [PDF]

BMC Neurol
Schmidt C, Becker L, Lindner D, Kleinschnitz C, Becker AW, Holle D, Scheffler A.   +6 more
europepmc   +1 more source

Efficacy and Tolerability of Erenumab and Topiramate for Prevention of Chronic Migraine: A Retrospective Cohort Study

Background and Objectives: Migraine is a chronic neurological disorder affecting approximately 14% of the global population. Beyond physical pain, migraines significantly impact individuals’ quality of life, influencing education, employment, and income ...
Mohamed Elshafei, Ranya Ibrahim Alzayori, Dalya Ibrahim Alzayori, Shyam Babu Chandran, Zainaba Suaad Ahmed Ruwayya, Eslam El Nebrisi   +5 more
core   +1 more source

Tracking migraine outcomes over time by age and monoclonal antibody type: a retrospective, single-center, real-world study. [PDF]

Front Neurol
Mattioli I, Rondina A, Lanfranchi A, Ceccardi G, Di Pasquale M, Cresta E, Pilotto A, Rao R, Padovani A.   +8 more
europepmc   +1 more source